trial

Screening Protocol for Research Participants

NCTId NCT01010620

as of 2026-07-01

Add to landscape Monitor this Ask about this

at a glance

Phase — · Completed

Enrollment 523 (actual)

Sponsored by University of Maryland, Baltimore County

Primary completion 2019-06-01

Synthesized from structured facts only — each point cited above.

Design & status

Phase

—

Status

Completed

Enrollment

523 (actual)

Study type

Observational

Allocation

—

Model

—

Masking

—

Start

2009-12

Primary completion

2019-06-01

Eligibility

ALL · 18 Years · 64 Years

Interventions & indications

Drugs

Various Screening psychiatric and medical assessments

Indications

Smoking Cocaine-Related Disorders Tobacco Use Disorder Substance Abuse Marijuana Abuse Schizophrenia Substance-Related Disorders Schizophrenia Tobacco Use Disorder Cocaine Abuse

Investigators

Deanna L. Kelly, Pharm.D., BCPPPrincipal Investigator

Sites

1 total

Catonsville, United States

Facts & assertions

4 sourced

Enrollment

523

Phase

Primary Completion Date

2019-06-01

Status

COMPLETED

relationships

The graph out of here

drug

Various Screening psychiatric and medical assessments

drug

lead_sponsor

University of Maryland, Baltimore County

company

indication

Smoking

indication

Cocaine-Related Disorders

indication

Tobacco Use Disorder

indication

investigator

Deanna L. Kelly, Pharm.D., BCPP

person